Mao; Can
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mao; Can.The latest application filed is for "heteroaromatic compounds as btk inhibitors".
- Mao; Can - Philadelphia PA
- Mao; Can - New Milford CT
| Patent | Date |
|---|---|
| Heteroaromatic compounds as BTK inhibitors Grant 10,875,852 - Bentzien , et al. December 29, 2 | 2020-12-29 |
| Heteroaromatic Compounds As Btk Inhibitors App 20190112302 - BENTZIEN; Joerg ; et al. | 2019-04-18 |
| Heteroaromatic compounds as BTK inhibitors Grant 10,138,229 - Bentzien , et al. Nov | 2018-11-27 |
| Heteroaromatic Compounds As Btk Inhibitors App 20180086748 - BENTZIEN; Joerg ; et al. | 2018-03-29 |
| Pyrazole compounds as BTK inhibitors Grant 9,828,364 - Bentzien , et al. November 28, 2 | 2017-11-28 |
| Heteroaromatic Compounds As Btk Inhibitors App 20170320867 - BENTZIEN; Joerg Martin ; et al. | 2017-11-09 |
| Pyrazole Compounds As Btk Inhibitors App 20160340339 - BENTZIEN; Joerg ; et al. | 2016-11-24 |
| Heteroaromatic Compounds As Btk Inhibitors App 20160031872 - BENTZIEN; Joerg Martin ; et al. | 2016-02-04 |
| Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists Grant 9,056,858 - Cook , et al. June 16, 2 | 2015-06-16 |
| Heteroaromatic Compounds As Btk Inhibitors App 20140045813 - BENTZIEN; Joerg Martin ; et al. | 2014-02-13 |
| Pyrazolopiperidine compounds as CCR1 receptor antagonists Grant 8,546,442 - Betageri , et al. October 1, 2 | 2013-10-01 |
| Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists App 20120322790 - BETAGERI; Rajashekhar ; et al. | 2012-12-20 |
| Indazole and Pyrazolopyridine Compounds As CCR1 Receptor Antagonists App 20120270870 - Cook; Brian Nicholas ; et al. | 2012-10-25 |
| Pyrazole compounds as CCR1 antagonists Grant 8,293,917 - Cook , et al. October 23, 2 | 2012-10-23 |
| Indazole compounds as CCR1 receptor antagonists Grant 8,263,597 - Kuzmich , et al. September 11, 2 | 2012-09-11 |
| Pyridinyl Compounds Useful As Intermediates App 20120136158 - COOK; Brian Nicholas ; et al. | 2012-05-31 |
| Azaindazole compounds as CCR1 receptor antagonists Grant 8,163,918 - Kuzmich , et al. April 24, 2 | 2012-04-24 |
| Azaindazole Compounds As CCR1 Receptor Antagonists App 20120035370 - COOK; Brian Nicholas ; et al. | 2012-02-09 |
| Indazole Compounds As CCR1 Receptor Antagonists App 20110294808 - KUZMICH; Daniel ; et al. | 2011-12-01 |
| Azaindazole compounds as CCR1 receptor antagonists Grant 8,063,065 - Cook , et al. November 22, 2 | 2011-11-22 |
| Pyrazole Compounds As CCR1 Antagonists App 20110230521 - Cook; Brian Nicholas ; et al. | 2011-09-22 |
| Indazole compounds as CCR1 receptor antagonists Grant 8,008,327 - DiSalvo , et al. August 30, 2 | 2011-08-30 |
| Azaindazole Compounds As CCR1 Receptor Antagonists App 20110086846 - COOK; Brian Nicholas ; et al. | 2011-04-14 |
| Indazole Compounds As CCR1 Receptor Antagonists App 20110034512 - Disalvo; Darren ; et al. | 2011-02-10 |
| Azaindazole compounds as CCR1 receptor antagonists Grant 7,879,873 - Cook , et al. February 1, 2 | 2011-02-01 |
| Azaindazole Compounds As CCR1 Receptor Antagonists App 20100093724 - COOK; Brian Nicholas ; et al. | 2010-04-15 |
| Substitute benzothiophene compounds Grant 7,329,764 - Chen , et al. February 12, 2 | 2008-02-12 |
| Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses Grant 6,974,870 - Cywin , et al. December 13, 2 | 2005-12-13 |
| Substitute benzothiophene compounds App 20050038104 - Chen, Zhidong ; et al. | 2005-02-17 |
| Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses App 20040180922 - Cywin, Charles L. ; et al. | 2004-09-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 